Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 182
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00077090 | Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer | ||
| NCT02541266 | Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation | ||
| NCT00867347 | Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer | ||
| NCT04584853 | PreOperative Endocrine Therapy for Individualised Care With Abemaciclib | ||
| NCT03177187 | Combination Study of AZD5069 and Enzalutamide. | ||
| NCT04270799 | Lung Nodule Imaging Biobank for Radiomics and AI Research | ||
| NCT04985266 | A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer | ||
| NCT02688257 | Assessing Treatment Response in Breast Cancer With Functional Imaging | ||
| NCT02705846 | Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations | ||
| NCT03506997 | Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer | ||
| NCT05734950 | Biological Characteristics of Older Women (> 70 Years) With ER Positive, HER2 Negative Early Breast Cancer | ||
| NCT06636526 | The i4i PRODICT™ Study: Evaluation of the i4i PRODICT™ Test in Different Ethnic Groups (The i4i PRODICT™ Study). | ||
| NCT03727698 | Prospective Evaluation of Radiotherapy Using Magnetic Resonance Image Guided Treatment | ||
| NCT02407509 | Phase I Trial of VS-6766 Alone and in Combination With Everolimus | ||
| NCT00107497 | Radiation Therapy in Treating Women With Localized Breast Cancer | ||
| NCT03809377 | Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2) | ||
| NCT01006564 | Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer | ||
| NCT02714621 | MR-HIFU for Recurrent Gynaecological Cancer | ||
| NCT00175838 | Primary Thrombocythaemia 1 Trial | ||
| NCT04686188 | Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer | ||
| NCT06423976 | Microbiome Molecular Charaterisation | ||
| NCT05613023 | A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT | ||
| NCT01505829 | Diffusion-weighted Imaging Study in Cancer of the Ovary | ||
| NCT00199901 | Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma | ||
| NCT05968417 | Myeloma Novel Drug Discovery Ver 1.2 | ||
| NCT00261456 | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer | ||
| NCT06630260 | 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours | ||
| NCT00253422 | Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors | ||
| NCT05533190 | Clinical Investigation of Wysa | ||
| NCT02928432 | SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone | ||
| NCT05581121 | PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer | ||
| NCT00002892 | Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma | ||
| NCT04151134 | Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning | ||
| NCT04842799 | Digital Delivery of Information About Genetic Testing for Breast Cancer | ||
| NCT04065269 | ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss | ||
| NCT01902667 | Preoperative Imaging in Retroperitoneal Sarcoma | ||
| NCT02375204 | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors | ||
| NCT05782361 | POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC | ||
| NCT02819752 | PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck | ||
| NCT02447549 | Study of Tumour Focused Radiotherapy for Bladder Cancer | ||
| NCT04509986 | GlobalSurg-CovidSurg Week | ||
| NCT00787514 | FR in Stored Plasma | ||
| NCT04802590 | Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma | ||
| NCT02525068 | A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC | ||
| NCT01937533 | Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer | ||
| NCT01331525 | The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer | ||
| NCT00033683 | Combination Chemotherapy in Treating Women With Resected Breast Cancer | ||
| NCT04595019 | Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer | ||
| NCT00532727 | Triple Negative Breast Cancer Trial | ||
| NCT03946202 | KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer |
